Home > Insider Trading > Filing (0001140361-13-045851)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1178711	Transcept Pharmaceuticals Inc	TSPT	Pharmaceutical Preparations (2834)	330960223

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1331693	Roumell Asset Management, Llc	2 Wisconsin Cir Suite 660 Chevy Chase MD 20815		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-12-10	9,470	$3.55	1,885,511	No	4	S	Indirect	FN
Common Stock	Disposition	2013-12-11	520	$3.53	1,884,991	No	4	S	Indirect	FN
Common Stock	Disposition	2013-12-11	500	$3.57	1,884,491	No	4	S	Indirect	FN

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	FN
No	4	S	Indirect	FN
No	4	S	Indirect	FN

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	300,000	Indirect	FN
Common Stock	24,490	Direct

Footnotes

Sales required to accomodate client-requested account liquidation.
Represents shares of common stock deemed to be owned beneficially by Roumell Asset Management, LLC ("RAM") solely as a result of its discretionary power over such shares as investment adviser to its clients.
Represents shares of common stock deemed to be owned beneficially by RAM solely as a result of its discretionary power over such shares as investment adviser to the Roumell Opportunistic Value Fund (the "Fund").
Represents shares held by Mr. Roumell. Mr. Roumell is President of RAM and holds a controlling percentage of its outstanding voting securities and, as a result of his position with and ownership of securities of RAM, Roumell could be deemed the beneficial of the shares beneficially owned by RAM and those held by the Fund. Mr. Roumell disclaims beneficial ownership of shares owned by RAM and the Fund except to the extent of his pecuniary interest in such shares.